Data released on Tuesday indicates a decline in clinician-provided abortions for the first time since the Supreme Court’s Dobbs decision, attributed to new regulations. It’s becoming more common to navigate abortions without direct doctor involvement.
The Supreme Court’s ruling overturned Roe v. Wade, effectively ending constitutional rights to abortion and creating a patchwork of access across states.
In 2023 and 2024, there had been a rise in abortions nationwide, and out-of-state travel for procedures had more than doubled. However, recent data from the Guttmacher Institute suggests that this trend is now reversing.
Analysis reveals that abortions provided by clinicians dropped by 5% in the first half of this year compared to the same period last year.
This decline is seen in 22 states that do not have a total abortion ban. It is most pronounced in states where a six-week ban is in place, as well as those bordering states that have total bans.
Patients traveling to states where abortions remain legal decreased by 8% in the first six months of this year compared to last year, though numbers remain “significantly higher” than before Roe was overturned, as noted by researchers.
Several factors could be behind this decline, although Guttmacher researchers stress that preliminary data may not fully capture annual trends.
They suggest that the drop likely stems from recent restrictions, the growing availability of medication abortions protected by the Shield Act, and increased travel difficulties for patients.
“With many states lacking a total ban, our data shows that travel remains a crucial option for care. However, it’s a costly and logistically challenging endeavor,” researchers emphasized.
Docampo highlighted that abortion funds—designed to help cover travel costs—are facing financial strain, particularly after donations have dwindled since the end of Roe v. Wade.
Moreover, methods that shield providers who operate in states where abortion is legal may be contributing to the decrease in clinician-provided abortions. Online clinics are expanding their services to support individuals in states where bans are active.
While Guttmacher’s report did not include data on abortions conducted under the Shield Act, the Family Planning Association noted an increase in those cases.
Researchers indicated, “Although Shield Act options may not suit everyone—like those in later gestation or who prefer procedural over medical abortions—this could impact travel needs significantly.”
However, the continuing wave of restrictions means that some individuals may lack nearby alternatives for access.
Florida had been a crucial access point in the Southeast, but following the instatement of a six-week ban in 2024, abortions saw a sharp decline.
Earlier Guttmacher data showed that, in the year following the Dobbs decision, about a third of abortions in the South and throughout the country were occurring in Florida.
Recent statistics, though, now indicate a reduction—over 12,000 abortions were reported in Florida, illustrating the largest absolute change of any state, accounting for more than 40% of the decline in states with no complete bans.
“Provisions to protect access and financial support for patients are critical for those in restrictive states who need abortion care. Given the rising urgency of threats to access, such measures are more essential than ever,” stated Kelly Baden, vice president of public policy at Guttmacher Institute.
